Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nevena Krnić is active.

Publication


Featured researches published by Nevena Krnić.


Pediatric Diabetes | 2015

Incidence of type 1 diabetes mellitus in 0 to 14‐yr‐old children in Croatia – 2004 to 2012 study

Nataša Rojnić Putarek; Jasenka Ille; Anita Špehar Uroić; Veselin Škrabić; Gordana Stipančić; Nevena Krnić; Ana Radica; Igor Marjanac; Srećko Severinski; Alen Svigir; Ana Bogdanic; Miroslav Dumić

The incidence of type 1 diabetes mellitus (T1DM) among children and adolescents increased during the last 50 yr. The T1DM incidence in Croatia was 8.87/100.000/yr over 1995–2003, with an annual increase of 9%, which placed Croatia among countries with moderate risk for T1DM.


Hormone Research in Paediatrics | 2009

Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Croatia between 1995 and 2006

Katja Dumic; Nevena Krnić; Veselin Škrabić; Gordana Stipančić; Katarina Cvijović; Vesna Kušec; Katarina Štingl

Aims: To evaluate the incidence, gender, symptoms and age at diagnosis among patients with classical congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency in Croatia. Methods: Data were collected retrospectively for all classical CAH patients born or electively aborted following prenatal diagnosis between 01.01.1995 and 31.12.2006 and were compared with the data of the previously conducted study evaluating CAH patients discovered between 1964 and 1984. Results: During a 12-year period, 34 classical CAH patients were born. There were 20 salt-wasting (SW) (12 females/8 males) and 14 simple virilizing (SV) patients (7 females/7 males). If 3 female fetuses, electively aborted, were added, that would be a total of 37 CAH patients. With 532,942 live births and 34 CAH patients born over this period, incidence of classical CAH was estimated to 1:15,574 or 1:14,403 if 3 electively aborted fetuses were included. The lower incidence of SW boys compared to SW girls (8:12) and similar number of SW and SV boys (8:7) indicate that substantial proportion of SW boys die unrecognized. Owing to better health care, diagnosis was established significantly earlier in SW and SV girls compared to the period of 1964–1984 (p < 0.003). During 1995–2006, none of the patients died following the diagnosis of CAH, and there was no erroneous sex assignment. Conclusion: Despite of improvement in health care, diagnosis of CAH in Croatia is still delayed and some of the patients go unrecognized or die. Therefore, we think that the results of our study support the need for the introduction of newborn screening.


HLA | 2016

Association of HLA alleles and haplotypes with CYP21A2 gene p. V282L mutation in the Croatian population

Zorana Grubić; Marija Maskalan; K. Stingl Jankovic; S. Zvecic; K. Dumic Kubat; Nevena Krnić; R. Zunec; J. Ille; Vesna Kusec; Miroslav Dumić

The CYP21A2 mutations that are in linkage disequilibrium with particular HLA‐A, ‐B, ‐DRB1 alleles/haplotypes, cause deficiency of the 21‐hydroxylase enzyme (21‐OHD) and account for the majority of congenital adrenal hyperplasia (CAH) cases. The aim of this study was to investigate those associations with the p.V282L mutation linked to the non‐classical (NC) form of CAH among Croatians. The study included parents of patients with the NC form of CAH, positive for the p.V282L mutation (N = 55) and cadaveric donor samples (N = 231). All subjects were HLA‐A, ‐B, and ‐DRB1 typed and tested for the presence of the p.V282L mutation. Among parents of patients, 92.73% of subjects were positive for the B*14:02 allele and almost half of them carried the HLA‐A*33:01‐B*14:02‐DRB1*01:02 haplotype. Among cadaveric samples 77 out of 96 subjects positive for the B*14:02 allele had the p.V282L mutation. Among them, 37 were positive for the HLA‐A*33:01‐B*14:02‐DRB1*01:02 haplotype, 23 had the HLA‐A*33:01‐B*14:02‐DRB1*03:01 haplotype, 8 had the B*14:02‐DRB1*01:02 combination and 5 were carrying the HLA‐A*68:02‐B*14:02‐DRB1*13:03 haplotype. Only 4 of these subjects were positive for the B*14:02 allele. HLA‐B*14:02 was the only single allele with association that reached statistically significant P value (RR = 12.00; P = 0.0024). Haplotypes B*14:02‐DRB1*01:02 (P < 0.001) and HLA‐A*68:02‐B*14:02‐DRB1*13:03 (P < 0.001) as well as HLA‐A*33:01‐B*14:02‐DRB1*01:02 and HLA‐A*33:01‐B*14:02‐DRB1*03:01 showed high relative risks (RR = 45.00, RR = 41.63 and RR = 36.96, respectively). Our data support the previously documented association of the HLA‐A*33:01‐B*14:02‐DRB1*01:02 haplotype with the p.V282L mutation, but also point out a high frequency of the p.V282L mutation among Croatians with HLA‐A*33:01‐B*14:02‐DRB1*03:01 and HLA‐A*68:02‐B*14:02‐DRB1*13:03 haplotypes.


The Central European Journal of Paediatrics | 2018

Severe virilization in adolescent girl with Sertoli-Leydig cell tumor – case report and review of the literature

Nevena Krnić; Nataša Rojnić Putarek; Katja Dumic Kubat; Mihajlo Strelec; Anita Spehar Uroic; Marija Macan; Lana Škrgatić; Vesna Kusec


Hormone Research in Paediatrics Volume 82 Supplement 1 | 2017

The Association of HLA Class II, CTLA-4 and PTPN22 Genetic Polymorphisms and β-Cell Autoantibodies in Development of Type I Diabetes in Patients with Autoimmune Thyroid Disease

Nataša Rojnić Putarek; Zorana Grubić; Danka Grčević; Vesna Kušec; Jadranka Knežević-Ćuća; Nevena Krnić; Anita Špehar Uroić; Maja Baretić; Miroslav Dumić


55th Annual ESPE | 2016

The Association of HLA Class II, CTLA-4 and PTPN22 Genetic Polymorphisms and [beta]-Cell Autoantibodies in Development of Type I Diabetes in Patients with Autoimmune Thyroid Disease

Nataša Rojnić Putarek; Zorana Grubić; Danka Grčević; Vesna Kušec; Jadranka Knezevic-Cuca; Nevena Krnić; Anita Špehar Uroić; Maja Baretić; Miroslav Dumić


Paediatria Croatica | 2015

Pretilost u djece - pogled iz Klinike Versus pristup u praksi

Eva Pavić; Valentina Uroić; Nataša Rojnić Putarek; Špehar Uroić Anita; Nevena Krnić; Jasenka Ille; Marina Grubić; Ana Bogdanić; Ivanka Gregurinčić; Marina Bedeković-Sliško; Gordana Čolig


Archive | 2015

Multidisciplinarni timski pristup liječenju pretilosti u djece i adolescenata

Nataša Rojnić Putarek; Jasenka Ille; Anita Špehar Uroić; Nevena Krnić; Marina Grubić; Ivanka Gregurinčić; Ana Bogdanić; Eva Pavić; Valentina Uroić; Danijel Jurakić; Gordana Čolig; Bedeković-Sliško, Marina, Giljević, Zlatko


54th Annual ESPE | 2015

Clinical, Biochemical and Molecular Characteristics of the Patients with Nonclassical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Croatia

Miroslav Dumić; Nevena Krnić; Vesna Kušec; Zorana Grubić; Katarina Štingl; Tony Yuen; Katja Dumic Kubat; Veselin Škrabić; Maria I. New


Priručnici stalnog medicinskog usavršavanja Medicinskog fakulteta Sveučilišta u Zagrebu | 2014

Pedijatrija danas ; novosti u nas i u svijetu

Josip Konja; Ranka Femenić; Ernest Bilić; Maja Pavlović; Nevena Krnić; Mirna Aničić; Ivo Barić; Vladimir Sarnavka; Karin Zibar; Ksenija Fumić; Kristina Crkvenac Gornik; Zorana Grubić; Katarina Štingl; Ivana Tonković Đurišević; Morana Mikloš; Sanda Huljev; Davor Begović; Danica Batinić; Danko Milošević; Milivoj Novak; Jasna Slaviček; Slobodan Galić; Miran Cvitković; Ljiljana Nižić; Kristina Vrljičak; Maja Lemac; Marijana Ćorić; Goran Tešović; Marija Jelušić; Dorian Tješić-Drinković

Collaboration


Dive into the Nevena Krnić's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zorana Grubić

University Hospital Centre Zagreb

View shared research outputs
Top Co-Authors

Avatar

Anita Špehar Uroić

University Hospital Centre Zagreb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Katarina Štingl

University Hospital Centre Zagreb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge